Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung CancerActive Not Recruiting
NCT03059940EARLY_Phase 1Updated Apr 15, 2026
Sponsor: M.D. Anderson Cancer Center
Smoking Cessation
United States
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).Recruiting
NCT06297161N/AUpdated Apr 14, 2026
Sponsor: Pfizer
Chronic Leukemia Myelogenous
United States
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA SuppressionActive Not Recruiting
NCT04920708Phase 2Updated Apr 14, 2026
Sponsor: Royal Marsden NHS Foundation Trust
Metastatic Breast Cancer · ER+ Breast Cancer · Advanced Breast Cancer
United Kingdom
Safety and Efficacy of Trastuzumab BSCompleted
NCT04181333N/AUpdated Apr 14, 2026
Sponsor: Pfizer
Gastric Cancer
Japan
A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"Recruiting
NCT07382739Phase 2Updated Apr 14, 2026
Sponsor: M.D. Anderson Cancer Center
Phase 2 · Radiotherapy-Induced Immune Priming · Elranatamab · Relapsed Refractory Multiple Myeloma (RRMM)
United States
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast CancerCompleted
NCT02630693Phase 2Updated Apr 13, 2026
Sponsor: Canadian Cancer Trials Group
Breast Cancer
Canada
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of AgeActive Not Recruiting
NCT07300839Phase 3Updated Apr 13, 2026
Sponsor: BioNTech SE
COVID-19 · SARS-COV-2 Infection
United States
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.Completed
NCT04744454N/AUpdated Apr 13, 2026
Sponsor: Pfizer
Aspergillosis · Mucormycosis
South Korea
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.Active Not Recruiting
NCT04767594N/AUpdated Apr 13, 2026
Sponsor: Pfizer
Breast Neoplasms
Austria, Germany
Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in JapanCompleted
NCT05399329N/AUpdated Apr 9, 2026
Sponsor: Pfizer
Breast Cancer
Japan
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerActive Not Recruiting
NCT03820830Phase 3Updated Apr 9, 2026
Sponsor: ETOP IBCSG Partners Foundation
Breast Cancer Recurrent
Austria, France, Hungary, Italy, Spain +1 more
TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast CancerActive Not Recruiting
NCT03964532Phase 1, Phase 2Updated Apr 9, 2026
Sponsor: Georgetown University
Breast Cancer
United States
Long-Term PF-06651600 for the Treatment of Alopecia AreataCompleted
NCT04006457Phase 3Updated Apr 9, 2026
Sponsor: Pfizer
Alopecia Areata
United States, Argentina, Australia, Canada, Chile +12 more
SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTSCompleted
NCT06482099N/AUpdated Apr 9, 2026
Sponsor: Pfizer
Respiratory Tract Infection
Japan
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerRecruiting
NCT04841148Phase 2Updated Apr 9, 2026
Sponsor: Abramson Cancer Center at Penn Medicine
Breast Cancer
United States
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaActive Not Recruiting
NCT04657991Phase 3Updated Apr 7, 2026
Sponsor: Pfizer
Melanoma
United States, Argentina, Austria, Belgium, Brazil +22 more
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding WomenRecruiting
NCT07153159Phase 1Updated Apr 7, 2026
Sponsor: Pfizer
Healthy Participant
Belgium
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsRecruiting
NCT05203172Phase 4Updated Apr 7, 2026
Sponsor: Pfizer
Solid Tumors
United States, Australia, Brazil, Canada, Czechia +12 more
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.Completed
NCT07514156Phase 1Updated Apr 7, 2026
Sponsor: Pfizer
Healthy Adults
Belgium
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)Recruiting
NCT02819882N/AUpdated Apr 7, 2026
Sponsor: Spanish Breast Cancer Research Group
Breast Neoplasms
Spain
Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing ChemotherapyCompleted
NCT01679119Phase 2Updated Apr 7, 2026
Sponsor: University College, London
Diffuse Large B Cell Lymphoma
United Kingdom
Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune RestorationCompleted
NCT00944541Phase 2Updated Apr 6, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infection · HIV Infections
France
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal MelanomaActive Not Recruiting
NCT05170334Phase 2Updated Apr 6, 2026
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Metastatic Uveal Melanoma
United States
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144Completed
NCT07198035Phase 1Updated Apr 3, 2026
Sponsor: Pfizer
Healthy Adults
Belgium
A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data SettingCompleted
NCT05478590N/AUpdated Apr 3, 2026
Sponsor: Pfizer
Breast Neoplasms
Poland

Previous page Next page